Jan-Henning Schierz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jan-Henning Schierz has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
- Martin Freesmeyer
Clinic of Nuclear Medicine, Jena University Hospital, 07747 Jena, Germany
7 shared publications - Thomas Winkens
Clinic of Nuclear Medicine, Jena University Hospital, 07747 Jena, Germany
6 shared publications Martin Freesmeyer
Clinic of Nuclear Medicine Jena University Hospital Jena Germany
3 shared publicationsT. Opfermann
Clinic of Nuclear Medicine, Jena University Hospital, Jena, Germany
3 shared publicationsAnke McLeod
Department of Nuclear Medicine, University of Leipzig, Germany
2 shared publicationsEric Lopatta
Institute of Diagnostic and Interventional Radiology, Jena University Hospital, Jena, Germany
2 shared publications
Latest Publications
- 31 January 2022
- Published by VM Media Group sp. z o.o in Nuclear Medicine Review
- Vol. 25 (1) , 68-69
Rare osteoarticular complications on [18F]FDG-PET/CT — following intravesical BCG immunotherapy for bladder cancer
This case illustrates rare osteoarticular complications of Bacillus Calmette-Guérin (BCG) immunotherapy in a 55-year-old male with high-risk non-muscle-invasive bladder cancer (NMIBC). The patient was referred for 18F-fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) to rule out bone metastases suspected on prior post-gadolinium magnetic resonance imaging (MRI). Although metastases were excluded, nearly symmetrical uptakes were detected in the costovertebral and costotransverse joints. Medical history revealed that the patient had been receiving intravesical instillations of BCG, the first-line therapy for high-risk NMIBC. The patient was diagnosed with reactive arthritis (ReA), a rare autoimmune complication of BCG, that was successfully treated with a nonsteroidal anti-inflammatory drug (NSAID). This case illustrates rare osteoarticular complications of Bacillus Calmette-Guérin (BCG) immunotherapy in a 55-year-old male with high-risk non-muscle-invasive bladder cancer (NMIBC). The patient was referred for 18F-fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) to rule out bone metastases suspected on prior post-gadolinium magnetic resonance imaging (MRI). Although metastases were excluded, nearly symmetrical uptakes were detected in the costovertebral and costotransverse joints. Medical history revealed that the patient had been receiving intravesical instillations of BCG, the first-line therapy for high-risk NMIBC. The patient was diagnosed with reactive arthritis (ReA), a rare autoimmune complication of BCG, that was successfully treated with a nonsteroidal anti-inflammatory drug (NSAID).
- 31 January 2022
- Published by VM Media Group sp. z o.o in Nuclear Medicine Review
- Vol. 25 (1) , 68-69
Rare osteoarticular complications on [18F]FDG-PET/CT — following intravesical BCG immunotherapy for bladder cancer
This case illustrates rare osteoarticular complications of Bacillus Calmette-Guérin (BCG) immunotherapy in a 55-year-old male with high-risk non-muscle-invasive bladder cancer (NMIBC). The patient was referred for 18F-fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) to rule out bone metastases suspected on prior post-gadolinium magnetic resonance imaging (MRI). Although metastases were excluded, nearly symmetrical uptakes were detected in the costovertebral and costotransverse joints. Medical history revealed that the patient had been receiving intravesical instillations of BCG, the first-line therapy for high-risk NMIBC. The patient was diagnosed with reactive arthritis (ReA), a rare autoimmune complication of BCG, that was successfully treated with a nonsteroidal anti-inflammatory drug (NSAID). This case illustrates rare osteoarticular complications of Bacillus Calmette-Guérin (BCG) immunotherapy in a 55-year-old male with high-risk non-muscle-invasive bladder cancer (NMIBC). The patient was referred for 18F-fluorodeoxyglucose ([18F]FDG) positron emission tomography/computed tomography (PET/CT) to rule out bone metastases suspected on prior post-gadolinium magnetic resonance imaging (MRI). Although metastases were excluded, nearly symmetrical uptakes were detected in the costovertebral and costotransverse joints. Medical history revealed that the patient had been receiving intravesical instillations of BCG, the first-line therapy for high-risk NMIBC. The patient was diagnosed with reactive arthritis (ReA), a rare autoimmune complication of BCG, that was successfully treated with a nonsteroidal anti-inflammatory drug (NSAID).
- 21 October 2021
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 47 (3) , 241-242
Risk of Upstaging Due to Oncofertility Treatment Mimicking Pelvic Lymphoma on 18F-FDG PET/CT
A 23-year-old woman with primary mediastinal large B-cell lymphoma was referred to 18F-FDG PET/CT for staging. Besides the large mediastinal FDG-avid tumor, another FDG-avid lesion with an SUV higher than expected in corpus luteum cysts was found in the pelvis, raising suspicion for tumor. However, gynecologic ultrasound and review of patient chart revealed history of oncofertility treatment with GNRH analog. This prior treatment was responsible for the intense 18F-FDG uptake within the left ovary, way above the SUV levels commonly associated with menstrual cycle. In this case, the disease was downgraded to stage II, resulting in a less aggressive treatment.
- 21 October 2021
- Published by Wolters Kluwer Health in Clinical Nuclear Medicine
- Vol. 47 (3) , 241-242
Risk of Upstaging Due to Oncofertility Treatment Mimicking Pelvic Lymphoma on 18F-FDG PET/CT
A 23-year-old woman with primary mediastinal large B-cell lymphoma was referred to 18F-FDG PET/CT for staging. Besides the large mediastinal FDG-avid tumor, another FDG-avid lesion with an SUV higher than expected in corpus luteum cysts was found in the pelvis, raising suspicion for tumor. However, gynecologic ultrasound and review of patient chart revealed history of oncofertility treatment with GNRH analog. This prior treatment was responsible for the intense 18F-FDG uptake within the left ovary, way above the SUV levels commonly associated with menstrual cycle. In this case, the disease was downgraded to stage II, resulting in a less aggressive treatment.
- 8 September 2021
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 49 (3) , 1086-1087
Vasculitis and bursitis on [18F]FDG-PET/CT following COVID-19 mRNA vaccine: post hoc ergo propter hoc?
- 8 September 2021
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 49 (3) , 1086-1087
Vasculitis and bursitis on [18F]FDG-PET/CT following COVID-19 mRNA vaccine: post hoc ergo propter hoc?
- 26 July 2016
- Published by Springer Nature in Der Chirurg
- Vol. 87 (11) , 956-963
Selektive interne Radioembolisation beim nichtresektablen hepatozellulären Karzinom Selective internal radioembolization in nonresectable hepatocellular carcinoma
The role of selective internal radioembolization (SIRT) in the treatment of hepatocellular carcinoma (HCC) is currently unclear.
- 26 July 2016
- Published by Springer Nature in Der Chirurg
- Vol. 87 (11) , 956-963
Selektive interne Radioembolisation beim nichtresektablen hepatozellulären Karzinom Selective internal radioembolization in nonresectable hepatocellular carcinoma
The role of selective internal radioembolization (SIRT) in the treatment of hepatocellular carcinoma (HCC) is currently unclear.
- 1 July 2014
- Published by Elsevier in Ultrasound in Medicine & Biology
- Vol. 40 (7) , 1453-1462
Multimodal Evaluation of 2-D and 3-D Ultrasound, Computed Tomography and Magnetic Resonance Imaging in Measurements of the Thyroid Volume Using Universally Applicable Cross-Sectional Imaging Software: A Phantom Study
- 1 July 2014
- Published by Elsevier in Ultrasound in Medicine & Biology
- Vol. 40 (7) , 1453-1462
Multimodal Evaluation of 2-D and 3-D Ultrasound, Computed Tomography and Magnetic Resonance Imaging in Measurements of the Thyroid Volume Using Universally Applicable Cross-Sectional Imaging Software: A Phantom Study
- 6 June 2014
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 28 (7) , 664-668
Contrast between hypervascularized liver lesions and hepatic parenchyma: early dynamic PET versus contrast-enhanced CT
To detect hypervascularized liver lesions, early dynamic (ED) 18F-FDG PET may be an alternative when contrast-enhanced (CE) imaging is infeasible. This retrospective pilot analysis compared contrast between such lesions and liver parenchyma, an important objective image quality variable, in ED PET versus CE CT. Twenty-eight hypervascularized liver lesions detected by CE CT [21 (75 %) hepatocellular carcinomas; mean (range) diameter 4.9 ± 3.5 (1–14) cm] in 20 patients were scanned with ED PET. Using regions of interest, maximum and mean lesional and parenchymal signals at baseline, arterial and venous phases were calculated for ED PET and CE CT. Lesional/parenchymal signal ratio was significantly higher (P < 0.005) with ED PET versus CE CT at the arterial phase and similar between the methods at the venous phase. In liver imaging, ED PET generates greater lesional–parenchymal contrast during the arterial phase than does CE CT; these observations should be formally, prospectively evaluated.
- 6 June 2014
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 28 (7) , 664-668
Contrast between hypervascularized liver lesions and hepatic parenchyma: early dynamic PET versus contrast-enhanced CT
To detect hypervascularized liver lesions, early dynamic (ED) 18F-FDG PET may be an alternative when contrast-enhanced (CE) imaging is infeasible. This retrospective pilot analysis compared contrast between such lesions and liver parenchyma, an important objective image quality variable, in ED PET versus CE CT. Twenty-eight hypervascularized liver lesions detected by CE CT [21 (75 %) hepatocellular carcinomas; mean (range) diameter 4.9 ± 3.5 (1–14) cm] in 20 patients were scanned with ED PET. Using regions of interest, maximum and mean lesional and parenchymal signals at baseline, arterial and venous phases were calculated for ED PET and CE CT. Lesional/parenchymal signal ratio was significantly higher (P < 0.005) with ED PET versus CE CT at the arterial phase and similar between the methods at the venous phase. In liver imaging, ED PET generates greater lesional–parenchymal contrast during the arterial phase than does CE CT; these observations should be formally, prospectively evaluated.
- 29 January 2014
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 28 (4) , 314-321
First experience with early dynamic 18F-NaF-PET/CT in patients with chronic osteomyelitis
Objective This study investigates whether early dynamic positron emission tomography/computed tomography (edPET/CT) using 18F-sodium fluoride-(18F-NaF) is feasible in depicting early phases of radiotracer distribution in patients with chronic osteomyelitis (COM). Methods A total of 12 ed18F-NaF-PET/CT examinations were performed on 11 consecutive patients (2 female, 9 male; age 53 ± 12 years) in list mode over 5 min starting with radiopharmaceutical injection before standard late 18F-NaF-PET/CT. Eight consecutive time intervals (frames) were reconstructed for each patient: four 15 s, then four 60 s. Several volumes of interest (VOI) were selected, representing the affected area as well as different reference areas within the bone and soft tissue. Maximum and mean ed standardized uptake values (edSUVmax, edSUVmean, respectively) were calculated in each VOI during each frame to measure early fluoride influx and accumulation. Results were compared between affected and non-affected (contralateral) bones. Results Starting in the 31–45 s frame, the affected bone area showed significantly higher edSUVmax and edSUVmean compared to the healthy contralateral region. The affected bone areas also significantly differed from non-affected contralateral regions in conventional late 18F-NaF-PET/CT. Conclusions This pilot study suggests that, in patients with COM, ed18F-NaF -PET offers additional information about early radiotracer distribution to standard 18F-NaF -PET/CT, similar to a three-phase bone scan. The results should be validated in larger trials which directly compare ed18F-NaF-PET to a three-phase bone scan.
- 29 January 2014
- Published by Springer Nature in Annals of Nuclear Medicine
- Vol. 28 (4) , 314-321
First experience with early dynamic 18F-NaF-PET/CT in patients with chronic osteomyelitis
Objective This study investigates whether early dynamic positron emission tomography/computed tomography (edPET/CT) using 18F-sodium fluoride-(18F-NaF) is feasible in depicting early phases of radiotracer distribution in patients with chronic osteomyelitis (COM). Methods A total of 12 ed18F-NaF-PET/CT examinations were performed on 11 consecutive patients (2 female, 9 male; age 53 ± 12 years) in list mode over 5 min starting with radiopharmaceutical injection before standard late 18F-NaF-PET/CT. Eight consecutive time intervals (frames) were reconstructed for each patient: four 15 s, then four 60 s. Several volumes of interest (VOI) were selected, representing the affected area as well as different reference areas within the bone and soft tissue. Maximum and mean ed standardized uptake values (edSUVmax, edSUVmean, respectively) were calculated in each VOI during each frame to measure early fluoride influx and accumulation. Results were compared between affected and non-affected (contralateral) bones. Results Starting in the 31–45 s frame, the affected bone area showed significantly higher edSUVmax and edSUVmean compared to the healthy contralateral region. The affected bone areas also significantly differed from non-affected contralateral regions in conventional late 18F-NaF-PET/CT. Conclusions This pilot study suggests that, in patients with COM, ed18F-NaF -PET offers additional information about early radiotracer distribution to standard 18F-NaF -PET/CT, similar to a three-phase bone scan. The results should be validated in larger trials which directly compare ed18F-NaF-PET to a three-phase bone scan.
- 1 January 2014
- Published by Georg Thieme Verlag KG in Nuklearmedizin-Nuclear Medicine
- Vol. 53 (03) , 117-122
Early dynamic 18F-FDG PET/CT to diagnose chronic osteomyelitis following lower extremity fractures
Aim: The study investigates whether early dynamic PET/CT (edPET/CT) using 18F-fluoro- deoxyglucose (FDG) discriminates between affected versus non-affected sites in patients with complicated, protracted fracture healing and suspected COM in the lower extremities. Patients, methods: In nine consecutive patients (1 woman, 8 men; age 54 ± 13 years), before standard late FDG-PET/CT, altogether 10 edFDG-PET/CT examinations were performed in list mode over 5 min starting with radiopharmaceutical injection. Eight consecutive time intervals (frames), four 15-s, then four 60-s, were reconstructed. For every patient, several volumes-of-interest were selected. To measure early FDG influx and accumulation, maximum and mean ed standardized uptake values (respectively, ed SUVmax, edSUVmean) were calculated in each volume-of-interest during each frame. Results were compared between affected and non-affected (contralateral) bone. Results: Starting in the 31-45s frame, the affected bone area showed significantly higher ed- SUVmax and edSUVmean than did the healthy contralateral region. In conventional PET/CT, affected bone areas also significantly differed from non-affected contralateral regions. Conclusion: This pilot study suggests that edFDG- PET may offer a less time consuming add on to standard FDG-PET/CT while being equally accurate. The results should be validated pros- pectively in larger trials. Ziel: Untersucht wurde, ob mit frühen dynamischen PET/CT-Aufnahmen (edPET/CT) unter Verwendung von 18F-Fluordesoxyglukose (FDG) bei Patienten mit kompliziertem, verzögertem Heilungsverlauf nach Fraktur der unteren Extremität zwischen betroffener und nicht betroffener Seite unterschieden werden kann. Patienten, Methoden: Bei neun konsekutiven Patienten (1 Frau, 8 Männer; Alter 54 ± 13) wurden vor einer Standard-PET/CT- Untersuchung 10 edPET/CT-Studien über 5 Minuten mittels List-Mode durchgeführt. Es erfolgte die Rekonstruktion von acht konsekutiven Zeitintervallen, vier 15-s und anschließend vier 60-s Intervalle. Zur Quantifizierung der frühen Anflutung und Anreicherung wurden in jedem Zeitintervall der maximale und mittlere ed-standardized uptake value (edSUVmax, edSUVmean) mit Hilfe von VOI (volume of interest) ermitttelt. Der Vergleich der betroffenen erfolgte mit der nicht betroffenen kontralateralen Extremität. Ergebnisse: Das betroffene Knochenareal zeigte bereits ab dem Zeitintervall 31-45s signifikant höhere edSUVmax und edSUVmean als die gesunde kontralaterale Seite. Im Standard- PET/CT konnte ebenfalls ein signifikanter Unterschied zwischen betroffener und gesunder Seite festgestellt werden. Schlussfolgerung: Die Ergebnisse dieser Pilotstudie lassen vermuten, dass edPET mit FDG eine schnellere aber ebenso präzise Zusatzuntersuchung zum Standard FDG-PET/CT darstellt. Das Potenzial sollte in einer prospektiven Studie mit größeren Fallzahlen validiert werden.
- 1 January 2014
- Published by Georg Thieme Verlag KG in Nuklearmedizin-Nuclear Medicine
- Vol. 53 (03) , 117-122
Early dynamic 18F-FDG PET/CT to diagnose chronic osteomyelitis following lower extremity fractures
Aim: The study investigates whether early dynamic PET/CT (edPET/CT) using 18F-fluoro- deoxyglucose (FDG) discriminates between affected versus non-affected sites in patients with complicated, protracted fracture healing and suspected COM in the lower extremities. Patients, methods: In nine consecutive patients (1 woman, 8 men; age 54 ± 13 years), before standard late FDG-PET/CT, altogether 10 edFDG-PET/CT examinations were performed in list mode over 5 min starting with radiopharmaceutical injection. Eight consecutive time intervals (frames), four 15-s, then four 60-s, were reconstructed. For every patient, several volumes-of-interest were selected. To measure early FDG influx and accumulation, maximum and mean ed standardized uptake values (respectively, ed SUVmax, edSUVmean) were calculated in each volume-of-interest during each frame. Results were compared between affected and non-affected (contralateral) bone. Results: Starting in the 31-45s frame, the affected bone area showed significantly higher ed- SUVmax and edSUVmean than did the healthy contralateral region. In conventional PET/CT, affected bone areas also significantly differed from non-affected contralateral regions. Conclusion: This pilot study suggests that edFDG- PET may offer a less time consuming add on to standard FDG-PET/CT while being equally accurate. The results should be validated pros- pectively in larger trials. Ziel: Untersucht wurde, ob mit frühen dynamischen PET/CT-Aufnahmen (edPET/CT) unter Verwendung von 18F-Fluordesoxyglukose (FDG) bei Patienten mit kompliziertem, verzögertem Heilungsverlauf nach Fraktur der unteren Extremität zwischen betroffener und nicht betroffener Seite unterschieden werden kann. Patienten, Methoden: Bei neun konsekutiven Patienten (1 Frau, 8 Männer; Alter 54 ± 13) wurden vor einer Standard-PET/CT- Untersuchung 10 edPET/CT-Studien über 5 Minuten mittels List-Mode durchgeführt. Es erfolgte die Rekonstruktion von acht konsekutiven Zeitintervallen, vier 15-s und anschließend vier 60-s Intervalle. Zur Quantifizierung der frühen Anflutung und Anreicherung wurden in jedem Zeitintervall der maximale und mittlere ed-standardized uptake value (edSUVmax, edSUVmean) mit Hilfe von VOI (volume of interest) ermitttelt. Der Vergleich der betroffenen erfolgte mit der nicht betroffenen kontralateralen Extremität. Ergebnisse: Das betroffene Knochenareal zeigte bereits ab dem Zeitintervall 31-45s signifikant höhere edSUVmax und edSUVmean als die gesunde kontralaterale Seite. Im Standard- PET/CT konnte ebenfalls ein signifikanter Unterschied zwischen betroffener und gesunder Seite festgestellt werden. Schlussfolgerung: Die Ergebnisse dieser Pilotstudie lassen vermuten, dass edPET mit FDG eine schnellere aber ebenso präzise Zusatzuntersuchung zum Standard FDG-PET/CT darstellt. Das Potenzial sollte in einer prospektiven Studie mit größeren Fallzahlen validiert werden.
- 24 November 2013
- Published by Wiley in Liver International
- Vol. 34 (2) , 322
Early dynamic PET/CT shows open portocaval shunt in a patient with liver cirrhosis
- 24 November 2013
- Published by Wiley in Liver International
- Vol. 34 (2) , 322
Early dynamic PET/CT shows open portocaval shunt in a patient with liver cirrhosis
- 12 May 2013
- Published by Wiley in Liver International
- Vol. 34 (1) , 161
Detectability of hypervascularity in early dynamic PET depends on tracer kinetics: 18F‐FDG versus 68Ga‐DOTATOC in hepatic NET metastasis
- 12 May 2013
- Published by Wiley in Liver International
- Vol. 34 (1) , 161
Detectability of hypervascularity in early dynamic PET depends on tracer kinetics: 18F‐FDG versus 68Ga‐DOTATOC in hepatic NET metastasis